Navigation Links
HUYA Bioscience International Expands Senior Management Team
Date:12/10/2015

SAN DIEGO, Dec. 10, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) today announced the appointment of Dmitri Kharkevitch, M.D., Ph.D., as Vice President, Clinical Development Oncology. This most recent addition to the senior management team supports the Company's expansion of its clinical development programs for the lead anti-cancer drug HBI-8000.

Dr. Kharkevitch has over 30 years of experience in oncology which includes 15 years in leadership positions within pharma and biotech covering clinical and medical affairs at Roche, Pfizer, Bristol-Myers Squibb, Vical, Antigenics and MD Anderson Cancer Center, Houston, TX.

Dr. Kharkevitch brings important experience in all phases of drug development for hematology and solid tumors. Moreover he has over 60 publications and patents that complement HUYA's expertise in immuno-oncology. His international regulatory experience includes IND and NDA submissions to both the FDA and EMA.

Dr. Kharkevitch's extensive experience in oncology clinical research and development comes at an important time for HUYA as we advance our lead oncology drug HBI-8000, a novel oral HDAC inhibitor with immunomodulatory properties, through clinical trials," said Mireille Gillings Ph.D., CEO of HUYA. "We welcome him to the HUYA Senior Management team."

Educated in Moscow, Russia Dr. Kharkevitch received his MD and PhD degrees from N.I. Pirogov Medical School and N.N. Blokhin Cancer Center.

About HUYA Bioscience International
HUYA is the leader in enabling and accelerating the global development of novel biopharmaceutical product opportunities originating in China. Extensive collaborations are established with Chinese biopharmaceutical, academic and commercial organizations to speed development and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio covering all therapeutic areas, HUYA has emerged as the partner-of-choice for maximizing the value of biopharmaceutical innovation in China. HUYA has offices in the U.S., Japan, South Korea and eight strategic locations across China. With the largest team of scientists working with Chinese innovators, HUYA identifies and advances promising drug candidates globally.

HUYA was awarded the Asia-Pacific Stevie® Award in the Health Products and Services & Pharmaceuticals category and a Gold Stevie Award in the Woman of the Year 2015 American Business Award category. For more information, please visit www.huyabio.com

Contact details:
Yiota Merianos
HUYA Corporate Communications
+1 858 353 1217
ymerianos@huyabio.com

 


'/>"/>
SOURCE HUYA Bioscience International
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Imago BioSciences Announces Preclinical Data on LSD1 Inhibitor at Annual Meeting of the American Society of Hematology (ASH)
2. HUYA Bioscience International Sponsors Best New Drug Category at SCRIP Awards
3. Cytos Biotechnology and Kuros Biosurgery to Combine to Create Kuros Biosciences
4. Emily Leproust Of Twist Bioscience Named 2015 Global Thinker By Foreign Policy Magazine
5. HUYA Bioscience International Announces A Strategic Alliance With The Korea Drug Development Fund
6. Aytu BioScience to Present at Two Upcoming Investor Conferences
7. Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference
8. Twist Bioscience To Present At The 2015 Piper Jaffray Healthcare Conference
9. Representative Scott Peters Visits Avelas Biosciences
10. ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
11. Proove Biosciences Appoints Eric Fung, M.D. Ph.D., as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... 2018 , ... Nationally recognized public accounting and consulting firm Cherry Bekaert ... the Firm’s Nashville practice, on her appointment to Launch Tennessee’s Board of ... Managing Partner of the Firm’s Nashville practice in December 2017 . In this role, ...
(Date:9/12/2018)... , ... September 10, 2018 , ... Franz Inc. ... Database technology, AllegroGraph , for Knowledge Graphs, and Semantic Web Company , ... solutions, today announced a partnership to develop the Noam Chomsky Knowledge Graph. ...
(Date:9/12/2018)... ... September 11, 2018 , ... Sterlitech ... sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) to their ... H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic nature of ...
(Date:9/7/2018)... ... , ... Now available on live stream, the NanoScientific Symposium on SPM at ... a panel of industry leaders from Harvard, Cornell, RPI, IBM, SUNY and more to ... in the field. Register today to be a part of the nanometrology conference ...
Breaking Biology Technology:
(Date:8/29/2018)... ... August 28, 2018 , ... ... the full power of positron emission tomography (PET), today launched its proprietary ... is helping clinicians and researchers study and cure debilitating diseases, earlier, and ...
(Date:8/23/2018)... ... ... mini Australian shepherd and a tripod. When Mandy was four years old, she broke her ... repair the leg and each time it was unsuccessful. Once she finally got her ... decided to amputate. With only one front leg, mobility in Mandy’s back legs became ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... today announced that Seattle-based Aptevo Therapeutics , a clinical-stage biotechnology company, ... the Genedata Biologics ® platform to facilitate expansion of their pipeline ...
Breaking Biology News(10 mins):